A Closer Look at 9 Analyst Recommendations For Procter & Gamble

9 analysts have expressed a variety of opinions on Procter & Gamble PG over the past quarter, offering a diverse set of opinions from bullish to bearish.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 4 3 2 0 0
Last 30D 0 1 0 0 0
1M Ago 3 1 0 0 0
2M Ago 1 0 1 0 0
3M Ago 0 1 1 0 0

Analysts have set 12-month price targets for Procter & Gamble, revealing an average target of $170.11, a high estimate of $182.00, and a low estimate of $160.00. This current average reflects an increase of 2.71% from the previous average price target of $165.62.

price target chart

Understanding Analyst Ratings: A Comprehensive Breakdown

In examining recent analyst actions, we gain insights into how financial experts perceive Procter & Gamble. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Lauren Lieberman Barclays Raises Overweight $170.00 $168.00
Steve Powers Deutsche Bank Lowers Buy $171.00 $172.00
Kaumil Gajrawala Jefferies Raises Buy $182.00 $175.00
Lauren Lieberman Barclays Raises Overweight $168.00 $165.00
Steve Powers Deutsche Bank Raises Buy $172.00 $170.00
Bill Chappell Truist Securities Raises Buy $175.00 $160.00
Jason English Goldman Sachs Announces Neutral $168.00 -
Bill Chappell Truist Securities Raises Hold $160.00 $155.00
Lauren Lieberman Barclays Raises Overweight $165.00 $160.00

Key Insights:

  • Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Procter & Gamble. This information offers a snapshot of how analysts perceive the current state of the company.
  • Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Procter & Gamble compared to the broader market.
  • Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Procter & Gamble's stock. This comparison reveals trends in analysts' expectations over time.

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Procter & Gamble's market standing. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Procter & Gamble analyst ratings.

Unveiling the Story Behind Procter & Gamble

Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. P&G sold its last remaining food brand, Pringles, to Kellogg in calendar 2012. Sales outside its home turf represent around 53% of the firm's consolidated total.

Procter & Gamble's Financial Performance

Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.

Revenue Growth: Over the 3 months period, Procter & Gamble showcased positive performance, achieving a revenue growth rate of 0.63% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.

Net Margin: Procter & Gamble's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 18.25% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): Procter & Gamble's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 7.6%, the company may encounter challenges in delivering satisfactory returns for shareholders.

Return on Assets (ROA): Procter & Gamble's ROA stands out, surpassing industry averages. With an impressive ROA of 3.07%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: Procter & Gamble's debt-to-equity ratio is below the industry average. With a ratio of 0.65, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

The Basics of Analyst Ratings

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!